文献速递牙周病

靶向NLRP3炎症小体减轻年龄相关实验性牙槽骨丢失

Targeting NLRP3 Inflammasome Reduces Age-Related Experimental Alveolar Bone Loss.
PubMed 文献 · J Dent Res · 2020-06-12

该研究通过体内外模型探讨NLRP3炎症小体在年龄相关牙槽骨丢失中的作用及抑制其活性的治疗潜力。老年小鼠牙槽骨质量差与巨噬细胞caspase-1激活及牙周膜和血清中IL-1β升高相关;Nlrp3缺失或MCC950抑制可减少老年小鼠牙槽骨丢失,主要影响骨吸收而非骨形成。

要点

  • NLRP3炎症小体介导老年小鼠牙槽骨丢失,抑制其活性可减少骨吸收。
  • MCC950抑制NLRP3可减轻老年小鼠牙槽骨丢失,对年轻小鼠无显著影响。
  • IL-1β促进RANKL诱导的破骨细胞分化,MCC950直接抑制破骨细胞分化。

核心结论

  • NLRP3炎症小体是年龄相关牙槽骨丢失的关键介质,靶向NLRP3可能成为控制年龄相关牙周退行性改变的新选择。

研究设计与样本

  • 采用体内和体外模型研究NLRP3炎症小体在年龄相关牙槽骨丢失中的作用及NLRP3抑制的治疗潜力。
  • 体内使用老年小鼠和年轻小鼠,比较Nlrp3缺失与野生型小鼠,并给予NLRP3抑制剂MCC950处理。
  • 体外使用骨髓来源巨噬细胞,研究IL-1β对RANKL诱导破骨细胞生成的影响及MCC950的直接作用。

主要发现

  • 老年小鼠牙槽骨质量差与巨噬细胞caspase-1激活及牙周膜和血清中IL-1β水平升高相关。
  • Nlrp3缺失的老年小鼠比同龄野生型小鼠骨量更好,其作用影响骨吸收而非骨形成。
  • MCC950处理显著抑制老年小鼠牙槽骨丢失并减少caspase-1激活,但对年轻小鼠无此效果。
  • 体外实验显示IL-1β促进RANKL诱导的骨髓来源巨噬细胞破骨细胞生成。
  • MCC950直接显著抑制破骨细胞分化,与抑制IL-1β产生无关。

临床怎么用

  • 针对NLRP3炎症小体的抑制可能为控制年龄相关牙周退行性改变提供新思路。
  • MCC950在老年小鼠中显示减少牙槽骨丢失的潜力,但尚未应用于临床。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The cause of chronic inflammatory periodontitis, which leads to the destruction of periodontal ligament and alveolar bone, is multifactorial. An increasing number of studies have shown the clinical significance of NLRP3-mediated low-grade inflammation in degenerative disorders, but its causal linkage to age-related periodontitis has not yet been elucidated. In this study, we investigated the involvement of the NLRP3 inflammasome and the therapeutic potential of NLRP3 inhibition in age-related alveolar bone loss by using in vivo and in vitro models. The poor quality of alveolar bones in aged mice was correlated with caspase-1 activation by macrophages and elevated levels of IL-1β, which are mainly regulated by the NLRP3 inflammasome, in periodontal ligament and serum, respectively. Aged mice lacking Nlrp3 showed better bone mass than age-matched wild-type mice via a way that affects bone resorption rather than bone formation. In line with this finding, treatment with MCC950, a potent inhibitor of the NLRP3 inflammasome, significantly suppressed alveolar bone loss with reduced caspase-1 activation in aged mice but not in young mice. In addition, our in vitro studies showed that the addition of IL-1β encourages RANKL-induced osteoclastogenesis from bone marrow-derived macrophages and that treatment with MCC950 significantly suppresses osteoclastic differentiation directly, irrelevant to the inhibition of IL-1β production. Our results suggest that the NLRP3 inflammasome is a critical mediator in age-related alveolar bone loss and that targeting the NLRP3 inflammasome could be a novel option for controlling periodontal degenerative changes with age.

来源:J Dent Res,查看原文。版权归原作者所有。

引用

  1. Zang Y, Song JH, Oh SH, et al. Targeting NLRP3 Inflammasome Reduces Age-Related Experimental Alveolar Bone Loss. J Dent Res. 2020. PMID: 32531176. doi:10.1177/0022034520933533

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。